CrushSCI.com
103.4Average days
83Median days
68Fastest days
181Longest days
2642025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

68 days

Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study

Authors
Shaohua Chen; Xiao Gan; Ping Lv; Qinggui Meng; Xiaocao Lin; Qingyun ZhangShow moreShow less
Affiliations
1. Department of Urology, Guangxi Medical University Cancer Hospital, Nanning, China; 2. Department of Urology, Wuzhou Workers’ Hospital, Wuzhou, ChinaShow moreShow less
Official full-text evidence DOI Publisher page
73 days

The Impact of Combretastatin A-4 on Cancer Cells and Circulating Tumor Cells (CTCs): A Multi-Assay Approach

Authors
Dimitrios Papakonstantinou; Vasileios Vardas; Despoina M. Varouhaki; Aikaterini Kotzamouratoglou; Karolina Mangani; Julia A. Ju; Catherine Alix-Panabières; Stuart S. Martin; Constantinos M. Athanassopoulos; Galatea KallergiShow moreShow less
Affiliations
1. Laboratory of Biochemistry/Metastatic Signaling, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, University Campus, Patras, Greece; 2. Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, University Campus, Patras, Greece; 3. Department of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA; 4. Laboratory of Rare Human Circulating Cells and Liquid Biopsy (LCCRH), University Medical Centre of Montpellier, Montpellier, France; 5. CREEC, MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France; 6. European Liquid Biopsy Society (ELBS), Hamburg, GermanyShow moreShow less
Official full-text evidence DOI Publisher page
83 days

Liposomal Doxorubicin Induces PD-L1-High Tumor-Associated Macrophages and Sensitizes Triple-Negative Breast Cancer to PD-L1 Blockade

Authors
Yu Zheng; Peng Zheng; Yidan Zheng; Zihan Xi; Tao HuangShow moreShow less
Affiliations
1. Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. Department of Thyroid Surgery, Fujian Medical University Union Hospital, Fuzhou, China; 3. Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaShow moreShow less
Official full-text evidence DOI Publisher page
112 days

Gastric Cancer-Derived Exosomes Activate Mast Cells via the SCF/c-KIT Pathway to Drive Angiogenesis and Metastasis

Authors
Shaoxiong Bai; Yilei Duan; Tian Yao; Yanan Shi; Xin Zhang; Xiaole Ma; Kai JiaShow moreShow less
Affiliations
1. Department of Gastrointestinal Surgery, First Hospital of Shanxi Medical University, Taiyuan, China; 2. Medical Department, First Hospital of Shanxi Medical University, Taiyuan, China; 3. Department of Gastrointestinal Surgery, Shanxi Cancer Hospital, Taiyuan, ChinaShow moreShow less
Official full-text evidence DOI Publisher page
181 days

DNA Polymerase θ Drives Colorectal Cancer Progression through Wnt/β-Catenin Activation and Shows Potential Association with Immunosuppressive Microenvironment Remodeling

Authors
Li Li; Jianhua Wang; Feilong Zhou; Lingjun Geng; Kongwang HuShow moreShow less
Affiliations
1. Department of General Surgery, The Fifth Affiliated Hospital of Anhui Medical University, Fuyang, China; 2. Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaShow moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.